Cempra (CEMP) Misses Q4 EPS by 1c, to Reduce Workforce
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cempra, Inc. (CEMP) PT Lowered to $4 at Stifel; Reiterates Hold
March 1, 2017 8:59 AM ESTStifel lowered its price target on Cempra, Inc. (NASDAQ: CEMP) to $4.00 (from $8.00) while maintaining a Hold rating. GAAP net loss of $31.5M, or $(0.60)/share, was wider than Consensus' $(0.55) estimates.
Analyst Stephen Willey commented, "Incremental solithromycin updates provided on managements 4Q16 earnings announcement/call... More
Cempra (CEMP) Underperform Rating Reiterated at Baird Post Q4
February 28, 2017 12:45 PM ESTJefferies analyst Brian Skorney reiterated his Underperform rating and $2 price target on Cempra, Inc. (NASDAQ: CEMP) following results.
Skorney commented, "Cempra reported in-line earnings in 4Q16, along with a host of trial discontinuations, failure in gonorrhea, and updates on discussions with... More
